These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
331 related items for PubMed ID: 8862227
1. Renal and vascular effects of chronic endothelin receptor antagonism in malignant hypertensive rats. Li JS, Schürch W, Schiffrin EL. Am J Hypertens; 1996 Aug; 9(8):803-11. PubMed ID: 8862227 [Abstract] [Full Text] [Related]
2. Antihypertensive effect of an endothelin receptor antagonist in DOCA-salt spontaneously hypertensive rats. Schiffrin EL, Sventek P, Li JS, Turgeon A, Reudelhuber T. Br J Pharmacol; 1995 Aug; 115(8):1377-81. PubMed ID: 8564194 [Abstract] [Full Text] [Related]
3. Effect of a nonselective endothelin antagonist on vascular remodeling in deoxycorticosterone acetate-salt hypertensive rats. Evidence for a role of endothelin in vascular hypertrophy. Li JS, Larivière R, Schiffrin EL. Hypertension; 1994 Aug; 24(2):183-8. PubMed ID: 8039842 [Abstract] [Full Text] [Related]
4. Effect of chronic ETA-selective endothelin receptor antagonism on blood pressure in experimental and genetic hypertension in rats. Schiffrin EL, Turgeon A, Deng LY. Br J Pharmacol; 1997 Jul; 121(5):935-40. PubMed ID: 9222550 [Abstract] [Full Text] [Related]
5. Renoprotective effects of a combined endothelin type A/type B receptor antagonist in experimental malignant hypertension. Kohno M, Yokokawa K, Yasunari K, Kano H, Minami M, Ueda M, Tatsumi Y, Yoshikawa J. Metabolism; 1997 Sep; 46(9):1032-8. PubMed ID: 9284892 [Abstract] [Full Text] [Related]
6. Vascular structure and expression of endothelin-1 gene in L-NAME-treated spontaneously hypertensive rats. Sventek P, Li JS, Grove K, Deschepper CF, Schiffrin EL. Hypertension; 1996 Jan; 27(1):49-55. PubMed ID: 8591887 [Abstract] [Full Text] [Related]
7. Effect of chronic treatment with two different ET(A) selective endothelin receptor antagonists on blood pressure and small artery structure of deoxycorticosterone acetate (DOCA)-salt hypertensive rats. Li JS, Turgeon A, Schiffrin EL. Am J Hypertens; 1998 May; 11(5):554-62. PubMed ID: 9633791 [Abstract] [Full Text] [Related]
8. Endothelin-1 gene expression and vascular hypertrophy in DOCA-salt hypertension compared to spontaneously hypertensive rats. Schiffrin EL, Lariviere R, Li JS, Sventek P, Touyz RM. Clin Exp Pharmacol Physiol Suppl; 1995 Dec; 22(1):S188-90. PubMed ID: 9072349 [Abstract] [Full Text] [Related]
9. Comparison of effect of endothelin antagonism and angiotensin-converting enzyme inhibition on blood pressure and vascular structure in spontaneously hypertensive rats treated with N omega-nitro-L-arginine methyl ester. Correlation with topography of vascular endothelin-1 gene expression. Li JS, Deng LY, Grove K, Deschepper CF, Schiffrin EL. Hypertension; 1996 Aug; 28(2):188-95. PubMed ID: 8707380 [Abstract] [Full Text] [Related]
10. Effect of chronic treatment of adult spontaneously hypertensive rats with an endothelin receptor antagonist. Li JS, Schiffrin EL. Hypertension; 1995 Apr; 25(4 Pt 1):495-500. PubMed ID: 7721389 [Abstract] [Full Text] [Related]
11. Endothelin-1 expression in blood vessels of DOCA-salt hypertensive rats treated with the combined ETA/ETB endothelin receptor antagonist bosentan. Larivière R, Sventek P, Thibault G, Schiffrin EL. Can J Physiol Pharmacol; 1995 Mar; 73(3):390-8. PubMed ID: 7544236 [Abstract] [Full Text] [Related]
12. Enhanced expression of endothelin-1 gene may cause blood pressure-independent vascular hypertrophy. Schiffrin EL, Larivière R, Li JS, Sventek P, Touyz RM. J Cardiovasc Pharmacol; 1995 Mar; 26 Suppl 3():S5-8. PubMed ID: 8587458 [Abstract] [Full Text] [Related]
13. Chronic endothelin receptor antagonist treatment of young spontaneously hypertensive rats. Li JS, Schiffrin EL. J Hypertens; 1995 Jun; 13(6):647-52. PubMed ID: 7594422 [Abstract] [Full Text] [Related]
14. Enhanced expression of the endothelin-1 gene in blood vessels of DOCA-salt hypertensive rats: correlation with vascular structure. Schiffrin EL, Larivière R, Li JS, Sventek P. J Vasc Res; 1996 Jun; 33(3):235-48. PubMed ID: 8924521 [Abstract] [Full Text] [Related]
15. Deoxycorticosterone acetate plus salt induces overexpression of vascular endothelin-1 and severe vascular hypertrophy in spontaneously hypertensive rats. Schiffrin EL, Larivière R, Li JS, Sventek P, Touyz RM. Hypertension; 1995 Apr; 25(4 Pt 2):769-73. PubMed ID: 7721430 [Abstract] [Full Text] [Related]
16. Function and expression of endothelin receptor subtypes in the kidneys of spontaneously hypertensive rats. Hocher B, Rohmeiss P, Zart R, Diekmann F, Vogt V, Metz D, Fakhury M, Gretz N, Bauer C, Koppenhagen K, Neumayer HH, Distler A. Cardiovasc Res; 1996 Apr; 31(4):499-510. PubMed ID: 8689641 [Abstract] [Full Text] [Related]
17. Endothelin antagonism in end-organ damage of spontaneously hypertensive rats. Comparison with angiotensin-converting enzyme inhibition and calcium antagonism. Karam H, Heudes D, Bruneval P, Gonzales MF, Löffler BM, Clozel M, Clozel JP. Hypertension; 1996 Sep; 28(3):379-85. PubMed ID: 8794820 [Abstract] [Full Text] [Related]
19. Effects of alpha-lipoic acid on deoxycorticosterone acetate-salt-induced hypertension in rats. Takaoka M, Kobayashi Y, Yuba M, Ohkita M, Matsumura Y. Eur J Pharmacol; 2001 Jul 20; 424(2):121-9. PubMed ID: 11476758 [Abstract] [Full Text] [Related]
20. Different contributions of endothelin-A and endothelin-B receptors in the pathogenesis of deoxycorticosterone acetate-salt-induced hypertension in rats. Matsumura Y, Hashimoto N, Taira S, Kuro T, Kitano R, Ohkita M, Opgenorth TJ, Takaoka M. Hypertension; 1999 Feb 20; 33(2):759-65. PubMed ID: 10024341 [Abstract] [Full Text] [Related] Page: [Next] [New Search]